Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new latest revision, v3.6.6, is added to the study's Record History. The previous revision, v3.6.5, is removed from the current list, reflecting an update to the record.
    Difference
    0.1%
    Check dated 2026-08-29T23:46:26.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the record history and the prior v3.6.4 entry was removed, indicating an update to the study's version history.
    Difference
    0.1%
    Check dated 2026-08-08T20:30:47.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision (v3.6.4) has been added to the Study Record History, replacing the previous revision (v3.6.3). This reflects an updated version of the record.
    Difference
    0.1%
    Check dated 2026-07-25T12:37:03.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry labeled v3.6.3, indicating the record has been updated to a newer saved version.
    Difference
    0.1%
    Check dated 2026-07-03T23:55:14.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision history now shows a new entry for v3.6.2 and removes the v3.6.0 entry, updating the page's version log. This reflects internal version control for the page and does not alter the study data or status.
    Difference
    0.1%
    Check dated 2026-06-26T22:57:40.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The study page now shows that recruitment is no longer open to participants, clarifying that enrollment has ended. The record history reflects a new revision (v3.6.0) replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T14:11:32.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.